Pioglitazone Mylan 15 mg compresse

DRUG2 trials

Sponsors

Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA, I.F.O. Istituti Fisioterapici Ospitalieri

Conditions

Type 2 Diabetes MellitusVitiligo

Phase 2

“A phase 2 multi-center study investigating the efficacy, safety and tolerability of pioglitazone in adult participants with non-segmental vitiligo”

Not yet recruitingCTIS2025-523266-24-00

I.F.O. Istituti Fisioterapici OspitalieriVitiligo

Target: 60Updated: 2025-11-26

Phase 4

Open-label, double-arm, controlled, randomized, multicentre clinical trial to evaluate the impact of pharmacogenetic-guided treatment in patients with insufficiently controlled type 2 diabetes

Active, not recruitingCTIS2025-520686-46-00

Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVAType 2 Diabetes Mellitus

Start: 2025-05-15Target: 504Updated: 2025-09-15